<div class="container">

<table style="width: 100%;"><tr>
<td>CFO2d.oc</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Generate operating characteristics of phase I drug-combination trials in multiple simulations</h2>

<h3>Description</h3>

<p>Based on the toxicity outcomes, this function is used to conduct multiple simulations of phase I drug-combination trials and obtain relevant the operating characteristics.
</p>


<h3>Usage</h3>

<pre><code class="language-R">CFO2d.oc(nsimu = 1000, target, p.true, init.level = c(1,1), ncohort, cohortsize,
               prior.para = list(alp.prior = target, bet.prior = 1 - target), 
               cutoff.eli = 0.95, early.stop = 0.95, seeds = NULL)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>nsimu</code></td>
<td>
<p>the total number of trials to be simulated. The default value is 1000.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>target</code></td>
<td>
<p>the target DLT rate.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>p.true</code></td>
<td>
<p>a matrix representing the true DIL rates under the different dose levels.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>init.level</code></td>
<td>
<p>a numeric vector of length 2 representing the initial dose level (default is <code>c(1,1)</code>).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>ncohort</code></td>
<td>
<p>the total number of cohorts.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>cohortsize</code></td>
<td>
<p>the number of patients of each cohort.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>prior.para</code></td>
<td>
<p>the prior parameters for a beta distribution, where set as <code>list(alp.prior = target, bet.prior = 1 - target)</code>
by default, <code>alp.prior</code> and <code>bet.prior</code> represent the parameters of the prior distribution for
the true DLT rate at any dose level. This prior distribution is specified as Beta(<code>alpha.prior</code>, <code>beta.prior</code>).</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>cutoff.eli</code></td>
<td>
<p>the cutoff to eliminate overly toxic doses for safety. We recommend
the default value of (<code>cutoff.eli = 0.95</code>) for general use.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>early.stop</code></td>
<td>
<p>the threshold value for early stopping. The default value <code>early.stop = 0.95</code>
generally works well.</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>seeds</code></td>
<td>
<p>A vector of random seeds for each simulation, for example, <code>seeds = 1:nsimu</code> (default is <code>NULL</code>).</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p>The <code>CFO.oc()</code> function returns basic setup of ($simu.setup) and the operating
characteristics of the design: <br></p>

<ul>
<li>
<p> p.true: the matrix of the true DLT rates under the different dose levels.
</p>
</li>
<li>
<p> selpercent: the matrix of the selection percentage of each dose level.
</p>
</li>
<li>
<p> npatients: a matrix of the averaged number of patients allocated to different doses in one simulation.
</p>
</li>
<li>
<p> ntox: a matrix of the averaged number of DLT observed for different doses in one simulation.
</p>
</li>
<li>
<p> MTDsel: the percentage of the correct selection of the MTD.
</p>
</li>
<li>
<p> MTDallo: the averaged percentage of patients assigned to the target DLT rate.
</p>
</li>
<li>
<p> oversel: the percentage of selecting a dose above the MTD.
</p>
</li>
<li>
<p> overallo: the averaged percentage of patients assigned to dose levels with a DLT rate greater than the target.
</p>
</li>
<li>
<p> averDLT: the averaged total number of DLTs observed.
</p>
</li>
<li>
<p> percentstop: the percentage of early stopping without selecting the MTD.
</p>
</li>
<li>
<p> simu.setup: the parameters for the simulation set-up.
</p>
</li>
</ul>
<h3>Note</h3>

<p>In the example, we set <code>nsimu = 10</code> for testing time considerations. In reality, <code>nsimu</code>
is typically set to 1000 or 5000 to ensure the accuracy of the results.
</p>


<h3>Author(s)</h3>

<p>Jialu Fang, Wenliang Wang, Ninghao Zhang, and Guosheng Yin
</p>


<h3>References</h3>

<p>Jin H, Yin G (2022). CFO: Calibration-free odds design for phase I/II clinical trials.
<em>Statistical Methods in Medical Research</em>, 31(6), 1051-1066. <br>
Wang W, Jin H, Zhang Y, Yin G (2023). Two-dimensional calibration-free odds (2dCFO)
design for phase I drug-combination trials. <em>Frontiers in Oncology</em>, 13, 1294258.
</p>


<h3>Examples</h3>

<pre><code class="language-R">## Simulate a two-dimensional dose-finding trial with 20 cohorts of size 3 for 10 replications.
p.true &lt;- matrix(c(0.05, 0.10, 0.15, 0.30, 0.45,
0.10, 0.15, 0.30, 0.45, 0.55,
0.15, 0.30, 0.45, 0.50, 0.60), 
nrow = 3, ncol = 5, byrow = TRUE)
target &lt;- 0.3; ncohort &lt;- 12; cohortsize &lt;- 3
CFO2doc &lt;- CFO2d.oc(nsimu = 5, target, p.true, init.level = c(1,1), ncohort, cohortsize, 
                    seeds = 1:5)
summary(CFO2doc)
plot(CFO2doc)
</code></pre>


</div>